Glycosyl Thiourea: Synthesis, Cyclization, Reaction, Molecular Docking, and Evaluation as Potential Acetylcholinesterase Inhibitors | ||||
| Egyptian Journal of Chemistry | ||||
| Volume 66, Issue 13, December 2023, Page 1759-1777 PDF (2.92 MB) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejchem.2023.244506.8770 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Salma A. Ellithy   1; Adel A-H Abdel-Rahman1; Nasser A. Hassan 2, 3; Mohamed Elsawalhy1; Eman S. Abou-Amra 4; Allam A. Hassan5
| ||||
| 1Department of Chemistry, Faculty of Science, Menoufia University, Shibin El-Kom 32511, Egypt. | ||||
| 2Department of Photochemistry (Synthetic Unit), National Research Centre, 12622 Cairo, Egypt. | ||||
| 3Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra 11961, Saudi Arabia. | ||||
| 4Department of Chemistry, Faculty of Science (Girls), Al-Azhar University, Nasr City, Cairo, Egypt. | ||||
| 5Department of Chemistry, Faculty of Science, Suez University, Suez 43221, Egypt. | ||||
| Abstract | ||||
| In this research, we successfully synthesized a distinctive group of iminothiazolidinone derivatives, using glucose isothiocyanate as the starting material. The structural elucidation of these newly created compounds was achieved through a combination of analytical techniques, including IR, 1H NMR, and 13C NMR. We then evaluated the inhibitory activity of these compounds against acetylcholinesterase (AChE) using the Ellman's method spectrophotometer, comparing their performance to standard drugs like donepezil, rivastigmine, and tacrine. Impressively, the majority of the tested compounds demonstrated inhibitory activity against AChE, with iminothiazolidinone derivative (5a) standing out as the most potent (IC50 = 0.209 μg/mL). It even surpassed the effectiveness of rivastigmine and tacrine, coming close to the potency of donepezil. Further investigation into the potential of these compounds as AChE inhibitors for Alzheimer's disease drug development involved docking simulations using Molecular Operating Environment (MOE). Derivatives 3,5-disubstituted-(2,3,4,6-tetra-o-acetyl-β-D-glucopyranosyl) imino) thiazolidin-4-ones (5a), (5f), (6c) and 3,5-disubstituted-(β-D-glucopyranosyl)imino)thiazolidin-4-one (6d) displayed promising docking scores in MOE simulations. In Silico ADMET experiments assessed their pharmacokinetic and toxicity studies, demonstrating strong binding affinity and favorable interactions with the target protein. Pharmacophore models confirmed their potential as selective enzyme inhibitors through 3D virtual screening. | ||||
| Keywords | ||||
| Thiazolidin-4-one; 2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl isothiocyanate; pharmacokinetics prediction; Alzheimer’s disease | ||||
|
Statistics Article View: 192 PDF Download: 131 |
||||
